The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study
Martinus P. G. Broen(Maastricht University), Martin J. van den Bent(Erasmus MC Cancer Institute), Alida A. Postma(Maastricht University), Marion Smits(Erasmus MC), Jan Beckervordersandforth(Maastricht University Medical Centre), Olaf Schijns(Maastricht University), Hendrikus J. Dubbink(Erasmus MC Cancer Institute), Monique Anten(Maastricht University), Maarten M.J. Wijnenga(Erasmus MC)
Cited by 205
Related Papers
Recommended implementation of arterial spin‐labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia
|Magnetic Resonance in Medicine|2014|2.2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k